Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Observational, Single-blinded, Longitudinal Study to Evaluate the Effect of Dimethyl Fumarate on Gray and White Matter Pathology in Subjects With Relapsing Multiple Sclerosis

NCT02686684 is registered in ClinicalTrials.gov with University at Buffalo as lead sponsor.

NCT NCT02686684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Observational, Single-blinded, Longitudinal Study to Evaluate the Effect of Dimethyl Fumarate on Gray and White Matter Pathology in Subjects With Relapsing Multiple Sclerosis
Lead sponsor
University at Buffalo
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
October 31, 2016
Enrollment
115 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, dimethyl fumarate, diffusion tensor imaging magnetic resonance imaging